Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis

Background The obesity-lung cancer association remains controversial. Concerns over confounding by smoking and reverse causation persist. The influence of obesity type and effect modifications by race/ethnicity and tumor histology are largely unexplored. Methods We examined associations of body mass index (BMI), waist circumference (WC), and waist-hip ratio (WHR) with lung cancer risk among 1.6 million Americans, Europeans, and Asians. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) with adjustment for potential confounders. Analyses for WC/WHR were further adjusted for BMI. The joint effect of BMI and WC/WHR was also evaluated. Results During an average 12-year follow-up, 23 732 incident lung cancer cases were identified. While BMI was generally associated with a decreased risk, WC and WHR were associated with increased risk after controlling for BMI. These associations were seen 10 years before diagnosis in smokers and never smokers, were strongest among blacks, and varied by histological type. After excluding the first five years of follow-up, hazard ratios per 5 kg/m2 increase in BMI were 0.95 (95% CI = 0.90 to 1.00), 0.92 (95% CI = 0.89 to 0.95), and 0.89 (95% CI = 0.86 to 0.91) in never, former, and current smokers, and 0.86 (95% CI = 0.84 to 0.89), 0.94 (95% CI = 0.90 to 0.99), and 1.09 (95% CI = 1.03 to 1.15) for adenocarcinoma, squamous cell, and small cell carcinoma, respectively. Hazard ratios per 10 cm increase in WC were 1.09 (95% CI = 1.00 to 1.18), 1.12 (95% CI = 1.07 to 1.17), and 1.11 (95% CI = 1.07 to 1.16) in never, former, and current smokers, and 1.06 (95% CI = 1.01 to 1.12), 1.20 (95% CI = 1.12 to 1.29), and 1.13 (95% CI = 1.04 to 1.23) for adenocarcinoma, squamous cell, and small cell carcinoma, respectively. Participants with BMIs of less than 25 kg/m2 but high WC had a 40% higher risk (HR = 1.40, 95% CI = 1.26 to 1.56) than those with BMIs of 25 kg/m2 or greater but normal/moderate WC. Conclusions The inverse BMI-lung cancer association is not entirely due to smoking and reverse causation. Central obesity, particularly concurrent with low BMI, may help identify high-risk populations for lung cancer.

[1]  W. Willett,et al.  Dietary Fat Intake and Lung Cancer Risk: A Pooled Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Kiemeney,et al.  Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study , 2017, PloS one.

[3]  R. Sinha,et al.  Prediagnostic Calcium Intake and Lung Cancer Survival: A Pooled Analysis of 12 Cohort Studies , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[4]  M. Shi,et al.  Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies , 2016, Nutrients.

[5]  E. Giovannucci,et al.  Estimating the Influence of Obesity on Cancer Risk: Stratification by Smoking Is Critical. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  A. Renehan,et al.  The Obesity Paradox in Cancer: a Review , 2016, Current Oncology Reports.

[7]  E. Riboli,et al.  Anthropometry and the Risk of Lung Cancer in EPIC. , 2016, American journal of epidemiology.

[8]  W. Willett,et al.  Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. , 2016, International journal of epidemiology.

[9]  A. Fournier,et al.  Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. , 2016, JAMA internal medicine.

[10]  W. Zhou,et al.  Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis , 2015, Scientific Reports.

[11]  M. Zwahlen,et al.  Adiposity and cancer risk: new mechanistic insights from epidemiology , 2015, Nature Reviews Cancer.

[12]  F. Nuttall,et al.  Body Mass Index , 2020, Definitions.

[13]  Tangchun Wu,et al.  Association of Body Mass Index with Chromosome Damage Levels and Lung Cancer Risk among Males , 2015, Scientific Reports.

[14]  D. Mutch,et al.  Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  K. Bhaskaran,et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.

[16]  K. Syrigos,et al.  Hormones of adipose tissue and their biologic role in lung cancer. , 2014, Cancer treatment reviews.

[17]  Gretchen L. Gierach,et al.  Anthropometric Measures and Physical Activity and the Risk of Lung Cancer in Never-Smokers: A Prospective Cohort Study , 2013, PloS one.

[18]  J. Palmer,et al.  Obesity in relation to lung cancer incidence in African American women , 2013, Cancer Causes & Control.

[19]  M. Decramer,et al.  Chronic obstructive pulmonary disease and comorbidities. , 2013, The Lancet. Respiratory medicine.

[20]  Lin Zhao,et al.  Obesity and incidence of lung cancer: A meta‐analysis , 2013, International journal of cancer.

[21]  Guanghui Wang,et al.  Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis , 2012, PloS one.

[22]  Gretchen L. Gierach,et al.  Body mass index and risk of lung cancer among never, former, and current smokers. , 2012, Journal of the National Cancer Institute.

[23]  T. Fairley,et al.  Racial and regional disparities in lung cancer incidence , 2012, Cancer.

[24]  H. Cena,et al.  Relationship between smoking and metabolic syndrome. , 2011, Nutrition reviews.

[25]  A. Nicholson,et al.  Non-small-cell lung cancer , 2011, The Lancet.

[26]  C. Kiyohara,et al.  Sex differences in lung cancer susceptibility: a review. , 2010, Gender medicine.

[27]  W. Koh,et al.  Body mass index and smoking-related lung cancer risk in the Singapore Chinese Health Study , 2009, British Journal of Cancer.

[28]  Mimi Y. Kim,et al.  Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative. , 2008, American journal of epidemiology.

[29]  F. Paccaud,et al.  Consequences of smoking for body weight, body fat distribution, and insulin resistance. , 2008, The American journal of clinical nutrition.

[30]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[31]  S. Lear,et al.  Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). , 2007, The American journal of clinical nutrition.

[32]  F. Perera,et al.  The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity , 2007, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[33]  T. Mizoue,et al.  Leanness, Smoking, and Enhanced Oxidative DNA Damage , 2006, Cancer Epidemiology Biomarkers & Prevention.

[34]  Remi Rabasa-Lhoret,et al.  Metabolic and body composition factors in subgroups of obesity: what do we know? , 2004, The Journal of clinical endocrinology and metabolism.

[35]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[36]  J. Cerhan,et al.  Differential association of body mass index and fat distribution with three major histologic types of lung cancer: evidence from a cohort of older women. , 2002, American journal of epidemiology.

[37]  John E Connett,et al.  Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.

[38]  Emiel F M Wouters,et al.  Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  S. Tsugane,et al.  Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC Study cohort I , 2002, International Journal of Obesity.

[40]  E. Sellers.  Pharmacogenetics and ethnoracial differences in smoking. , 1998, JAMA.

[41]  E. Rimm,et al.  Validity of Self‐Reported Waist and Hip Circumferences in Men and Women , 1990, Epidemiology.

[42]  A. Folsom,et al.  Accuracy and reliability of self-measurement of body girths. , 1988, American journal of epidemiology.

[43]  R. Medeiros,et al.  The role of inflammation in lung cancer. , 2014, Advances in experimental medicine and biology.

[44]  A. Gregor,et al.  Small cell lung cancer. , 1997, Lung cancer.